According to Johns Hopkins researcher Daniel Brennan, MD, over the past several years, reports describing the administration of pembrolizumab or other immune checkpoint inhibitors (ICI) to solid organ transplant recipients (SOTR) with advanced cancers have emerged with increasing frequency.
An abstract is unavailable.
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care
Answer each quiz question to better understand the patient’s journey and determine the correct diagnosis. Wolters Kluwer (“we” or “us”) wants to inform you about…
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care
An abstract is unavailable.
An abstract is unavailable.
An abstract is unavailable.
An abstract is unavailable.
